Teleflex appoints Sean M. Salmon to board; expands to nine directors

TELEFLEX INC

Sean M. Salmon appointed to Teleflex board effective Sept 8, 2026; board grows from 8 to 9 directors.
Salmon, 61, ex-Medtronic EVP & President of Cardiovascular (fiscal 2025 revenue ~$12.5B), brings 30+ yrs medtech experience.
He also joins Growth and Operating Committee; 8 of 9 directors now independent; one-third of board refreshed in 2026.
Salmon currently independent director at Adagio Medical (Nasdaq: ADGM); no related-party transactions disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.